Patient correlates of patient-provider communication and financial toxicity in Black and White patients with cancer.
Abstract
e13730 Background: Financial toxicity, the burden of treatment cost, affects up to half of people with cancer and can affect survival. Financial toxicity is a health equity issue, disproportionately affecting Black patients. This cross-sectional study used baseline data from the Discussions of Cost (DISCO) Trial, an RCT to improve patient-provider treatment cost discussions and, in turn, mitigate financial toxicity, to examine whether Black and White patients differed in patient-provider communication perceptions and financial toxicity correlates. Methods: Data were collected from 2021-2025 at an NCI-designated comprehensive cancer center. Participants were Black or White patients diagnosed with solid tumor cancers. At baseline, patients completed demographic measures; communication measures of self-efficacy in patient-provider interactions (e.g., “I am confident I know what questions to ask a provider”); self-efficacy in managing cancer treatment costs (e.g., “I am confident I can understand treatment costs”); and whether they have a provider- or patient-centered approach (e.g., “the provider should decide what gets talked about”); and financial measures including economic burden (e.g., “it’s difficult to live on my income”); treatment cost distress (e.g., “worries about paying for my cancer treatment keep me up at night”); and anticipated material hardship (e.g., “I worry about the financial problems I will have in the future as a result of my treatment”). Comparisons were conducted by patient race. Results: A total of 202 patients participated (116 Black patients, 86 White patients). White patients were more likely to have advanced degrees, a higher annual income, and less likely to have Medicaid compared to Black patients. Black patients reported higher self-efficacy for managing treatment costs ( p = .002) and a higher provider-focused orientation to the patient-provider relationship ( p = .001), than White patients. Black patients reported greater levels of financial burden ( p < .001), cost distress ( p = .005), and anticipated material hardship ( p = .003). There was no difference in self-efficacy for interacting with providers. Conclusions: These results suggest that a communication intervention for patients may help mitigate the experience of financial toxicity, especially for Black patients. Clinical trial information: NCT04766190 . Patient characteristics. Black Patients White Patients p -value Race 116 86 Education < High School High School/GED Some College 2 or 4-year College Degree Graduate/Professional College Trade/Technical/Vocational School 10352626712 0141631187 < .001 Annual Household Income 0 - $19,999 $20,000 - 39,999 $40,000 - 59,999 $60,000 - 79,999 $80,000 - 99,999 $100,000 - 149,999 $150,000 + 53201611431 51215991716 <.001 Insurance Type* Medicaid Medicare Medicare supplement Private None 604911330 113726393 <.001>.99<.001.20.15 *Patients could select more than one
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (19)
Lauren M. Hamel
Wayne State University School of Medicine, Karmanos Cancer Institute, Detroit, MI
David W. Dougherty
Penn Medicine-Abramson Cancer Center, Philadelphia, PA
Seongho Kim
1Karmanos Cancer Institute, Detroit, United States
Elisabeth I. Heath
Department of Medical Oncology, Mayo Clinic Rochester, Rochester, MN
Lorna Mabunda
Karmanos Cancer Center, Wayne State University, Detroit, MI
Teneisha Austin
Karmanos Cancer Center, Wayne State University, Detroit, MI
Hadeel Assad
Barbara Ann Karmanos Cancer Institute, Detroit, MI
Hirva Mamdani
Mohammed Najeeb Al Hallak
Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
Helda Bacall
Karmanos Cancer Center, Detroit, MI
Adrienne Bouyer
Karmanos Cancer Institute, Detroit, MI
Frank Cameron Cackowski
Karmanos Cancer Institute, Wayne State University, Detroit, MI
Radhika Gogoi
Wayne State University/Karmanos Cancer Institute, Detroit, MI
Erica Goldman
Karmanos Cancer Institute, Detroit, MI
Ira Seth Winer
Division of Gynecologic Oncology, Department of Oncology, Wayne State University and Karmanos Cancer Center, Detroit, MI
Eliza W. Beal
Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI
Nouran Jarbo
Wayne State University, Detroit, MI
Keri Angers
Wayne State University, Detroit, MI
Susan Eggly
2Wayne State University Karmanos Cancer Institute, Detroit, United States